Edition:
United Kingdom

Aarti Drugs Ltd (ADRG.NS)

ADRG.NS on National Stock Exchange of India

549.85INR
18 May 2018
Change (% chg)

Rs-12.40 (-2.21%)
Prev Close
Rs562.25
Open
Rs562.65
Day's High
Rs562.75
Day's Low
Rs546.00
Volume
5,252
Avg. Vol
16,438
52-wk High
Rs785.00
52-wk Low
Rs447.80

Chart for

About

Aarti Drugs Limited is a pharmaceutical company. The Company offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins. Its products under APIs include Aceclofenac, Diclofenac Potassium,... (more)

Overall

Beta: 1.07
Market Cap(Mil.): Rs13,257.08
Shares Outstanding(Mil.): 23.58
Dividend: 1.00
Yield (%): 0.18

Financials

  ADRG.NS Industry Sector
P/E (TTM): 16.54 28.57 32.53
EPS (TTM): 33.24 -- --
ROI: -- 13.08 12.63
ROE: -- 14.80 14.50

BRIEF-Aarti Drugs Says Unit Affected Due To Explosion In Adjoining Unit In Tarapur

* SAYS CO'S UNIT ADVERSELY AFFECTED DUE TO MASSIVE EXPLOSION IN ADJOINING UNIT E-107 OF NOVAPHENE SPECIALTIES IN TARAPUR

09 Mar 2018

BRIEF-India's Aarti Drugs Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL PROFIT 233.3 MILLION RUPEES VERSUS PROFIT 178.5 MILLION RUPEES YEAR AGO

13 Feb 2018

BRIEF-India's Aarti Drugs Approves Buyback Of Equity Shares

* SAYS BUYBACK OF EQUITY SHARES WORTH UP TO 240.6 MILLION RUPEES Source text - http://bit.ly/2m7c2c3 Further company coverage:

08 Jan 2018

BRIEF-Aarti Drugs To Consider Proposal Of Buyback Of Fully Paid-Up Equity Shares Of Co

* TO CONSIDER PROPOSAL OF BUYBACK OF FULLY PAID-UP EQUITY SHARES OF CO Source text for Eikon: Further company coverage:

03 Jan 2018

Earnings vs. Estimates